GSK 4112

antagonist of the Nuclear Heme Receptor REV-ERB CAS# 1216744-19-2

GSK 4112

Package In Stock

Catalog No. BCC7741----Order now to get a substantial discount!

Product Name & Size Price Stock
GSK 4112: 5mg $58 In Stock
GSK 4112: 10mg Please Inquire In Stock
GSK 4112: 20mg Please Inquire Please Inquire
GSK 4112: 50mg Please Inquire Please Inquire
GSK 4112: 100mg Please Inquire Please Inquire
GSK 4112: 200mg Please Inquire Please Inquire
GSK 4112: 500mg Please Inquire Please Inquire
GSK 4112: 1000mg Please Inquire Please Inquire
Related Products
  • TCS 21311

    Catalog No.:BCC2443
    CAS No.:1260181-14-3
  • SB 216763

    Catalog No.:BCC3650
    CAS No.:280744-09-4
  • Indirubin

    Catalog No.:BCN2385
    CAS No.:479-41-4
  • AZD2858

    Catalog No.:BCC4509
    CAS No.:486424-20-8
  • GSK-3 inhibitor 1

    Catalog No.:BCC4126
    CAS No.:603272-51-1
  • LY2090314

    Catalog No.:BCC1717
    CAS No.:603288-22-8

Quality Control of GSK 4112

Chemical structure

GSK 4112

3D structure

Number of papers citing our products

Chemical Properties of GSK 4112

Cas No. 1216744-19-2 SDF Download SDF
PubChem ID 50905018 Appearance Powder
Formula C18H21ClN2O4S M.Wt 396.89
Type of Compound N/A Storage Desiccate at -20°C
Synonyms SR 6452
Solubility Soluble to 25 mM in DMSO
Chemical Name tert-butyl 2-[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]acetate
SMILES CC(C)(C)OC(=O)CN(CC1=CC=C(C=C1)Cl)CC2=CC=C(S2)[N+](=O)[O-]
Standard InChIKey WYSLOKHVFKLWOU-UHFFFAOYSA-N
Standard InChI InChI=1S/C18H21ClN2O4S/c1-18(2,3)25-17(22)12-20(10-13-4-6-14(19)7-5-13)11-15-8-9-16(26-15)21(23)24/h4-9H,10-12H2,1-3H3
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of GSK 4112

DescriptionSelective Rev-Erbα agonist (EC50 = 250 nM). Enhances recruitment of nuclear receptor co-repressor (NCoR) peptide to Rev-Erbα; causes acute suppression of Bmal1 gene transcription. Induces phase shifts in the circadian clock.

GSK 4112 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

GSK 4112 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of GSK 4112

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.5196 mL 12.5979 mL 25.1959 mL 50.3918 mL 62.9897 mL
5 mM 0.5039 mL 2.5196 mL 5.0392 mL 10.0784 mL 12.5979 mL
10 mM 0.252 mL 1.2598 mL 2.5196 mL 5.0392 mL 6.299 mL
50 mM 0.0504 mL 0.252 mL 0.5039 mL 1.0078 mL 1.2598 mL
100 mM 0.0252 mL 0.126 mL 0.252 mL 0.5039 mL 0.6299 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on GSK 4112

IC50: 2.3 μM

GSK4112 is a synthetic antagonist of the Nuclear Heme Receptor REV-ERB.

Rev-erbα and Rev-erbβ are heme sensors and atypical members of the nuclear receptor superfamily. As a member of the nuclear receptor superfamily, REV-ERBR functions as a receptor for the porphoryin heme. REV-ERBR can suppress the transcription of its target genes in a heme-dependent manner.

In vitro: Previous study showed that GSK4112 addition to either the REV-ERBR or REV-ERBβ assay led to enhanced repression. Cells were treated the with GSK4112 and similar pattern in GAL4 chimeric receptor assay was observed. In addition, GSK4112 suppressed reporter gene expression. GSK4112 also suppressed transcription driven by the Bmal1 promoter dose-dependently. GSK4112 activity was found to be associated with REV-ERBR [1].

In vivo: GSK4112 was found to display poor pharmacokinetic properties (rat liver microsomal Cint > 1.0 mL/min/mg protein; lack of oral bioavailability (F < 1% in mice)), which likely limited its use to biochemical and cell-based assays. As a result, GSK4112 was unlikely to be suitable for in vivo studies [1].

Clinical trial: N/A

Reference:
[1] Daniel Grant,Lei Yin,Jon L.  Collins et al. GSK4112, a small molecule chemical probe for the cell biology of the nuclear Heme receptor Rev-erbα. ACS CHEMICAL BIOLOGY5(10):925-32.

Featured Products
New Products
 

References on GSK 4112

The nuclear receptor and clock gene REV-ERBalpha regulates cigarette smoke-induced lung inflammation.[Pubmed:28974420]

Biochem Biophys Res Commun. 2017 Dec 2;493(4):1390-1395.

REV-ERBalpha is a nuclear heme receptor, transcriptional repressor and critical component of the molecular clock that drives daily rhythms of metabolism. Evidence reveals that REV-ERBalpha also plays an important regulatory role in clock-dependent lung physiology and inflammatory responses. We hypothesize that cigarette smoke (CS) exposure influences REV-ERBalpha abundance in the lungs, facilitating a pro-inflammatory phenotype. To determine the impact of REV-ERBalpha activation in the CS-induced inflammatory response we treated primary human small airway epithelial cells (SAECs) with CS extract (CSE) or lipopolysaccharide (LPS) in the absence or presence of pre-treatment with the REV-ERBalpha agonist GSK 4112. We also exposed adult C57BL/6J (WT) and Rev-erbalpha global KO mice to CS (10 and 30 days) and measured pro-inflammatory cytokine release. Our data reveal that pre-treatment with GSK 4112 reduced CSE/LPS induced pro-inflammatory cytokines release from both SAECs and mouse lung fibroblasts (MLFs). Furthermore, REV-ERBalpha KO mice show a greater inflammatory response to 10 and 30 days of CS, including increased neutrophil lung influx, pro-inflammatory cytokine (IL-6, MCP-1 and KC) release, and pro-senescence marker (p16) when compared to WT mice. These data demonstrate that REV-ERBalpha is a critical regulator of CS-induced lung inflammatory responses.

Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB.[Pubmed:21043485]

ACS Chem Biol. 2011 Feb 18;6(2):131-4.

REV-ERBalpha is a member of the nuclear receptor superfamily that functions as a receptor for the porphoryin heme. REV-ERBalpha suppresses transcription of its target genes in a heme-dependent manner. Recently, the first nonporphyrin synthetic ligand for REV-ERBalpha, GSK4112, was designed, and it mimics the action of heme acting as agonist. Here, we report the identification of the first REV-ERB antagonist, SR8278. SR8278 is structurally similar to the agonist but blocks the ability of the GSK4112 to enhance REV-ERBalpha-dependent repression in a cotransfection assay. Additionally, whereas GSK4112 suppresses the expression of REV-ERBalpha target genes involved in gluconeogenesis, SR8278 stimulates the expression of these genes. Thus, SR8278 represents a unique chemical tool for probing REV-ERB function and may serve as a point for initiation of further optimization to develop REV-ERB antagonists with the ability to explore circadian and metabolic functions.

Description

GSK4112 is a Rev-erbα agonist with EC50 of 0.4 μM, also is a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα.

Keywords:

GSK 4112,1216744-19-2,SR 6452,Natural Products,Nuclear Receptors, buy GSK 4112 , GSK 4112 supplier , purchase GSK 4112 , GSK 4112 cost , GSK 4112 manufacturer , order GSK 4112 , high purity GSK 4112

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: